Ginkgo Bioworks (NYSE:DNA) and Evo Foods have sealed a partnership to develop animal-free egg products. Demand for animal-free food is surging. However, scientists have found it challenging to replicate the nutritional properties found in real eggs, a problem that Ginkgo will begin tackling. DNA stock opened at $2.14 on May 12.
Many consumers have previously disregarded animal-free egg products, preferring the original product. Nonetheless, Ginkgo Bioworks and Evo Foods believe they’ve cracked the code by leveraging India’s crop biodiversity, which allows them to create a range of egg substitute products.
The post Ginkgo Bioworks’ Animal-Free Eggs Make DNA Stock Enticing appeared first on InvestorPlace.